To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
Dr Eddie Mullen is a consultant psychiatrist working with young people aged 15-25 at Orygen Specialist Services, an Early Intervention program based in Western Melbourne since 2013. He specialises in working with young people with a dual diagnosis of substance use and mental health disorders as well as with severe Borderline Personality Disorder. Dr Mullen provides clinical care to young people with substance use disorders as well as training staff in brief interventions, smoking cessation and opiate overdose prevention. He has presented a part of substance use symposia at international meetings such as the Congress of the World Psychiatric Association and the International Society for Study of Personality Disorders.
Dr Mullen is a member of the Substance Use Research Group at Orygen and an investigator on 3 clinical trials related to smoking cessation and methamphetamine abuse. He is interested in researching the link between substance use and mental health disorders, new treatments for young people and improving knowledge of harms associated with substance use. Dr Mullen is also member of the Royal Australia and New Zealand College of Psychiatrists Alcohol Harms Advisory Working Group that is currently developing a public campaign to raise awareness of the links between alcohol use and mental health issues and the role of psychiatrists in treatment and recovery.
MethAmphetamine use in young people: Sub-anaesthetic Ketamine Open-label Trial (MASKOT).
Dr Mullen will conduct a clinical trial of ketamine for methamphetamine use in youth. He will complete his fellowship under the mentorship of Dr Gillinder Bedi, Head of Substance Use Research at Orygen, and a Senior Research Fellow of University of Melbourne. The fellowship will involve the protocol design, and the ethical and clinical governance approval; a systematic literature review of other pharmacotherapies for substance abuse in youth; and the governance and implementation. He will also assist in the design of a new Research Project Data Management System for collecting and analysing completed project data.